Across TCGA pan-cancer cohorts, ADTRP mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated ADTRP data layer compared with 22 for mass-spec protein and 6 for mutation status.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ADTRP mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated ADTRP expression acts as an unfavorable survival marker.
UCEC are the cancer types where ADTRP mass-spec protein most reproducibly stratifies survival.